BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/20/2024 8:53:19 AM | Browse: 477 | Download: 1199
Publication Name World Journal of Clinical Oncology
Manuscript ID 89296
Country United States
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Neurosciences
Manuscript Type Review
Article Title Updates on management of gliomas in the molecular age
Manuscript Source Invited Manuscript
All Author List Ali Ahmed Mohamed, Rakan Alshaibi, Steven Faragalla, Youssef Mohamed and Brandon Lucke-Wold
ORCID
Author(s) ORCID Number
Ali Ahmed Mohamed http://orcid.org/0000-0002-0977-0365
Brandon Lucke-Wold http://orcid.org/0000-0001-6577-4080
Funding Agency and Grant Number
Corresponding Author Brandon Lucke-Wold, MD, PhD, Neurosurgeon, Researcher, Department of Neurosurgery, University of Florida, No. 1505 SW Archer Rd, Gainesville, FL 32611, United States. brandon.lucke-wold@neurosurgery.ufl.edu
Key Words Gliomas; Chemotherapy; Radiotherapy; Isocitrate dehydrogenase type mutant; Pediatric gliomas; Astrocytoma; Oligodendroglioma; 1p/19q-codeleted
Core Tip Gliomas are primary brain tumors derived from glial cells of the central nervous system, afflicting both adults and children. This review article explores the therapeutic modalities employed for both adult and pediatric gliomas in the context of their molecular classification. Gliomas are classified by World Health Organization using a grading system grade 1 to 4 differentiating the grades by the gliomas attributes such as progression. The current trident approach to glioma treatment is surgery, radiotherapy, and chemotherapy. Pediatric cases are more nuanced, creating a more challenging approach to treating pediatric gliomas compared to their adult counterpart.
Publish Date 2024-02-20 08:53
Citation Mohamed AA, Alshaibi R, Faragalla S, Mohamed Y, Lucke-Wold B. Updates on management of gliomas in the molecular age. World J Clin Oncol 2024; 15(2): 178-194
URL https://www.wjgnet.com/2218-4333/full/v15/i2/178.htm
DOI https://dx.doi.org/10.5306/wjco.v15.i2.178
Full Article (PDF) WJCO-15-178-with-cover.pdf
Full Article (Word) WJCO-15-178.docx